GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 165 filers reported holding GOSSAMER BIO INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $135,358 | -56.9% | 112,798 | -54.8% | 0.00% | -50.0% |
| Q1 2023 | $314,133 | -11.4% | 249,312 | +52.6% | 0.00% | 0.0% |
| Q4 2022 | $354,576 | -94.2% | 163,399 | -68.1% | 0.00% | -94.1% |
| Q3 2022 | $6,131,000 | +1031.2% | 511,791 | +691.1% | 0.03% | +1033.3% |
| Q2 2022 | $542,000 | -35.2% | 64,696 | -32.8% | 0.00% | -57.1% |
| Q1 2022 | $836,000 | +29.8% | 96,262 | +69.0% | 0.01% | +16.7% |
| Q4 2021 | $644,000 | -31.7% | 56,958 | -24.1% | 0.01% | -50.0% |
| Q3 2021 | $943,000 | +727.2% | 75,018 | +432.2% | 0.01% | +1100.0% |
| Q2 2021 | $114,000 | -71.4% | 14,096 | -67.3% | 0.00% | -80.0% |
| Q1 2021 | $398,000 | +161.8% | 43,054 | +173.1% | 0.01% | +150.0% |
| Q4 2020 | $152,000 | -74.8% | 15,765 | -67.6% | 0.00% | -77.8% |
| Q3 2020 | $604,000 | +18.9% | 48,697 | +24.6% | 0.01% | 0.0% |
| Q2 2020 | $508,000 | – | 39,088 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
| Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
| Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
| Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
| Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
| HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
| MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
| Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
| Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |